Clearance of neoplastic cells from mixed cellular compositions using viruses

Details for Australian Patent Application No. 2001258077 (hide)

Owner Oncolytics Biotech Inc.

Inventors Thompson, Bradley G.; Morris, Donald; Coffey, Matthew C.

Agent Cullen & Co

Pub. Number AU-B-2001258077

PCT Pub. Number WO01/83710

Priority 60276782 16.03.01 US; 60201990 03.05.00 US; 60205389 19.05.00 US; 60268054 13.02.01 US

Filing date 1 May 2001

Wipo publication date 12 November 2001

Acceptance publication date 20 July 2006

International Classifications

C12N 5/06 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines -

A61K 35/12 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Materials from mammals or birds

A61K 35/76 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61L 2/00 (2006.01) Disinfection or sterilising

C12N 15/861 (2006.01) Mutation or genetic engineering - Adenoviral vectors

Event Publications

21 April 2005 Amendment Made

  The nature of the amendment is: Amend the name of the applicant/patentee from Oncolytics Biotech, Inc. to Oncolytics Biotech Inc.

20 July 2006 Application Accepted

  Published as AU-B-2001258077

16 November 2006 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001258078

2001258076